NCT02303821 2025-06-04
Study of Carfilzomib in Combination With Induction Chemotherapy in Children With Relapsed or Refractory Acute Lymphoblastic Leukemia
Amgen
Phase 1 Completed
Clinical Trials
1 trialsPrecursor Cell Lymphoblastic Leukemia-Lymphoma × WW Domain-Containing Oxidoreductase × 1 year × Clear all